AUPH AURINIA PHARMACEUTICALS INC More: the full row for AURINIA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,429,500 shares; 2025Q1: 10,029,500 shares; 2025Q2: 10,029,500 shares; 2025Q3: 11,329,500 shares; 2025Q4: 11,329,500 shares; 2026Q1: 12,229,500 shares; 2026Q2: 13,044,106 shares; 2026Q3: 13,044,106 shares 13,044,106 $211M 9.72% 0 Timeline CORT CORCEPT THERAPEUTICS INC More: the full row for CORCEPT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 156,764 shares; 2026Q1: 1,500,000 shares; 2026Q2: 1,500,000 shares; 2026Q3: 1,500,000 shares 1,500,000 $173M 7.95% 0 Timeline KNSA KINIKSA PHARMACEUTICALS INTL More: the full row for KINIKSA PHARMACEUTICALS INTL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 628,609 shares; 2025Q1: 2,118,579 shares; 2025Q2: 2,328,609 shares; 2025Q3: 2,328,609 shares; 2025Q4: 2,259,889 shares; 2026Q1: 2,259,889 shares; 2026Q2: 2,259,889 shares; 2026Q3: 2,259,889 shares 2,259,889 $169M 7.76% 0 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 2,050,000 shares; 2025Q2: 3,200,000 shares; 2025Q3: 3,200,000 shares; 2025Q4: 1,892,200 shares; 2026Q1: 1,892,200 shares; 2026Q2: 1,892,200 shares; 2026Q3: 1,892,200 shares 1,892,200 $168M 7.75% 0 Timeline TARS TARSUS PHARMACEUTICALS INC More: the full row for TARSUS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,254,797 shares; 2025Q1: 2,454,797 shares; 2025Q2: 2,454,797 shares; 2025Q3: 2,454,797 shares; 2025Q4: 1,188,624 shares; 2026Q1: 1,188,624 shares; 2026Q2: 1,568,266 shares; 2026Q3: 1,917,666 shares 1,917,666 $151M 6.93% +349,400 Timeline LKFT LAKEFRONT BIOTHERAPEUTICS NV More: the full row for LAKEFRONT BIOTHERAPEUTICS NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,161,200 shares; 2025Q1: 3,961,797 shares; 2025Q2: 3,990,111 shares; 2025Q3: 4,151,194 shares; 2025Q4: 3,921,219 shares; 2026Q1: 3,785,991 shares; 2026Q2: 3,785,991 shares; 2026Q3: 3,985,991 shares 3,985,991 $118M 5.44% +200,000 Timeline CELC CELCUITY INC More: the full row for CELCUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,150,000 shares; 2025Q4: 1,050,000 shares; 2026Q1: 1,050,000 shares; 2026Q2: 1,314,594 shares; 2026Q3: 1,464,594 shares 1,464,594 $116M 5.36% +150,000 Timeline MIRM MIRUM PHARMACEUTICALS INC More: the full row for MIRUM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,237,107 shares; 2025Q1: 1,237,107 shares; 2025Q2: 1,236,027 shares; 2025Q3: 1,236,027 shares; 2025Q4: 1,236,027 shares; 2026Q1: 1,236,027 shares; 2026Q2: 1,236,027 shares; 2026Q3: 1,236,027 shares 1,236,027 $106M 4.86% 0 Timeline PTCT PTC THERAPEUTICS INC More: the full row for PTC THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 700,000 shares; 2025Q1: 1,000,000 shares; 2025Q2: 1,100,000 shares; 2025Q3: 1,500,000 shares; 2025Q4: 1,500,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 1,500,000 shares; 2026Q3: 1,500,000 shares 1,500,000 $97.2M 4.47% 0 Timeline IMCR IMMUNOCORE HLDGS PLC More: the full row for IMMUNOCORE HLDGS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,555,600 shares; 2025Q1: 1,915,708 shares; 2025Q2: 2,105,608 shares; 2025Q3: 2,305,608 shares; 2025Q4: 2,628,538 shares; 2026Q1: 2,649,368 shares; 2026Q2: 2,649,368 shares; 2026Q3: 2,884,149 shares 2,884,149 $87.4M 4.02% +234,781 Timeline ANAB ANAPTYSBIO INC More: the full row for ANAPTYSBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,330,879 shares; 2025Q1: 1,545,153 shares; 2025Q2: 1,330,879 shares; 2025Q3: 1,333,639 shares; 2025Q4: 1,332,087 shares; 2026Q1: 1,330,879 shares; 2026Q2: 1,330,879 shares; 2026Q3: 1,474,262 shares 1,474,262 $74.1M 3.41% +143,383 Timeline SPY STATE STR SPDR S&P 500 ETF T More: the full row for STATE STR SPDR S&P 500 ETF T Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 168,000 shares; 2026Q2: 123,000 shares; 2026Q3: 95,000 shares 95,000 $72.4M 3.33% -28,000 Timeline CMPS COMPASS PATHWAYS PLC More: the full row for COMPASS PATHWAYS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,000,000 shares; 2025Q1: 1,400,000 shares; 2025Q2: 1,300,000 shares; 2025Q3: 2,200,000 shares; 2025Q4: not reported; 2026Q1: 4,002,200 shares; 2026Q2: 5,000,000 shares; 2026Q3: 5,200,000 shares 5,200,000 $64.7M 2.98% +200,000 Timeline PGEN PRECIGEN INC More: the full row for PRECIGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 12,400,000 shares; 2025Q4: 5,617,500 shares; 2026Q1: 6,417,500 shares; 2026Q2: 6,417,500 shares; 2026Q3: 6,417,500 shares 6,417,500 $54.9M 2.53% 0 Timeline ANIP ANI PHARMACEUTICALS INC More: the full row for ANI PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 317,500 shares; 2025Q1: 317,500 shares; 2025Q2: 317,500 shares; 2025Q3: 317,500 shares; 2025Q4: 481,437 shares; 2026Q1: 707,500 shares; 2026Q2: 707,500 shares; 2026Q3: 707,500 shares 707,500 $51.4M 2.36% 0 Timeline BNTX BIONTECH SE More: the full row for BIONTECH SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 270,000 shares; 2025Q1: 270,000 shares; 2025Q2: 270,000 shares; 2025Q3: 270,000 shares; 2025Q4: 470,000 shares; 2026Q1: 470,000 shares; 2026Q2: 470,000 shares; 2026Q3: 470,000 shares 470,000 $46.2M 2.13% 0 Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,492,925 shares; 2025Q1: 2,792,925 shares; 2025Q2: 2,842,925 shares; 2025Q3: 2,842,925 shares; 2025Q4: 1,792,626 shares; 2026Q1: 1,792,626 shares; 2026Q2: 1,792,626 shares; 2026Q3: 1,792,626 shares 1,792,626 $36.9M 1.7% 0 Timeline NVCT NUVECTIS PHARMA INC More: the full row for NUVECTIS PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,550,000 shares; 2026Q3: 1,577,968 shares 1,577,968 $33.3M 1.53% +27,968 Timeline NNDM NANO DIMENSION LTD More: the full row for NANO DIMENSION LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 14,292,813 shares; 2026Q3: 20,926,847 shares 20,926,847 $32.9M 1.51% +6,634,034 Timeline ARDX ARDELYX INC More: the full row for ARDELYX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 9,047,134 shares 9,047,134 $30.9M 1.42% new 2026-11-09, 13G : 14,336,247 shares, 5.7% of the class, 13G filed 2026-11-17 Timeline FULC FULCRUM THERAPEUTICS INC More: the full row for FULCRUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,521,412 shares; 2026Q3: 7,080,945 shares 7,080,945 $26.2M 1.21% +559,533 Timeline AVIR ATEA PHARMACEUTICALS INC More: the full row for ATEA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,788,912 shares; 2025Q1: 4,800,000 shares; 2025Q2: 4,889,200 shares; 2025Q3: 4,826,200 shares; 2025Q4: 4,814,700 shares; 2026Q1: 4,814,700 shares; 2026Q2: 4,814,700 shares; 2026Q3: 4,814,700 shares 4,814,700 $25.1M 1.15% 0 2026-10-06, 13G : 4,814,700 shares, 6% of the class, 13G filed 2026-10-06 Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 264,692 shares; 2025Q1: 264,692 shares; 2025Q2: 264,692 shares; 2025Q3: 264,692 shares; 2025Q4: 264,692 shares; 2026Q1: 264,692 shares; 2026Q2: 264,692 shares; 2026Q3: 264,692 shares 264,692 $23.3M 1.07% 0 Timeline CMPX COMPASS THERAPEUTICS INC More: the full row for COMPASS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,900,000 shares; 2025Q1: 11,052,632 shares; 2025Q2: 13,496,208 shares; 2025Q3: 16,811,963 shares; 2025Q4: 16,790,809 shares; 2026Q1: 16,790,809 shares; 2026Q2: 17,990,782 shares; 2026Q3: 17,990,782 shares 17,990,782 $18.7M 0.86% 0 Timeline NUVB NUVATION BIO INC More: the full row for NUVATION BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,900,000 shares; 2025Q1: 3,900,000 shares; 2025Q2: 3,900,000 shares; 2025Q3: 4,200,000 shares; 2025Q4: 3,857,457 shares; 2026Q1: 3,149,557 shares; 2026Q2: 3,299,557 shares; 2026Q3: 3,299,557 shares 3,299,557 $18.5M 0.85% 0 Timeline IDYA IDEAYA BIOSCIENCES INC More: the full row for IDEAYA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 400,000 shares; 2025Q4: 450,000 shares; 2026Q1: 450,000 shares; 2026Q2: 450,000 shares; 2026Q3: 450,000 shares 450,000 $17.3M 0.8% 0 Timeline CBIO CRESCENT BIOPHARMA INC. More: the full row for CRESCENT BIOPHARMA INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,152 shares; 2025Q3: 679,824 shares; 2025Q4: 872,398 shares; 2026Q1: 1,160,000 shares; 2026Q2: 1,160,000 shares; 2026Q3: 1,160,000 shares 1,160,000 $16.9M 0.78% 0 Timeline VKTX VIKING THERAPEUTICS INC More: the full row for VIKING THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 320,000 shares; 2025Q1: 270,000 shares; 2025Q2: 370,000 shares; 2025Q3: 870,000 shares; 2025Q4: 500,000 shares; 2026Q1: 500,000 shares; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000 $16.3M 0.75% 0 Timeline VERA VERA THERAPEUTICS INC More: the full row for VERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 150,000 shares; 2025Q2: 1,350,000 shares; 2025Q3: 1,350,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000 $16.1M 0.74% new Timeline LEGN LEGEND BIOTECH CORP More: the full row for LEGEND BIOTECH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 450,000 shares; 2025Q1: 830,000 shares; 2025Q2: 830,000 shares; 2025Q3: 830,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 700,000 shares 700,000 $13.9M 0.64% new Timeline PMVP PMV PHARMACEUTICALS INC More: the full row for PMV PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,785,201 shares; 2025Q4: 4,940,000 shares; 2026Q1: 4,245,085 shares; 2026Q2: 4,245,085 shares; 2026Q3: 7,285,085 shares 7,285,085 $12.2M 0.56% +3,040,000 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 100,000 shares; 2025Q1: 100,000 shares; 2025Q2: 200,000 shares; 2025Q3: 200,000 shares; 2025Q4: 60,000 shares; 2026Q1: 260,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000 $11.4M 0.53% 0 Timeline DERM JOURNEY MED CORP More: the full row for JOURNEY MED CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,725,569 shares; 2025Q1: 1,854,596 shares; 2025Q2: 1,854,596 shares; 2025Q3: 1,854,596 shares; 2025Q4: 1,854,596 shares; 2026Q1: 1,610,000 shares; 2026Q2: 1,610,000 shares; 2026Q3: 1,610,000 shares 1,610,000 $11M 0.51% 0 Timeline MRNA MODERNA INC More: the full row for MODERNA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 300,000 shares; 2025Q1: 305,300 shares; 2025Q2: 305,300 shares; 2025Q3: 305,300 shares; 2025Q4: 692,820 shares; 2026Q1: 100,000 shares; 2026Q2: 50,000 shares; 2026Q3: 50,000 shares 50,000 $9.63M 0.44% 0 Timeline STOK STOKE THERAPEUTICS INC More: the full row for STOKE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 300,000 shares; 2025Q1: 500,000 shares; 2025Q2: 500,000 shares; 2025Q3: 500,000 shares; 2025Q4: 500,000 shares; 2026Q1: 500,000 shares; 2026Q2: 300,000 shares; 2026Q3: 300,000 shares 300,000 $7.8M 0.36% 0 Timeline BOLD BOUNDLESS BIO INC More: the full row for BOUNDLESS BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,559,875 shares; 2026Q3: 2,840,635 shares 2,840,635 $7.13M 0.33% +280,760 2026-11-20, Form 4 : bought 39,920 shares on 2026-11-20 Timeline PLRX PLIANT THERAPEUTICS INC More: the full row for PLIANT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 6,000,000 shares; 2025Q2: 6,000,000 shares; 2025Q3: 6,003,446 shares; 2025Q4: 6,143,132 shares; 2026Q1: 6,143,132 shares; 2026Q2: 6,141,261 shares; 2026Q3: 6,141,261 shares 6,141,261 $6.63M 0.31% 0 Timeline HRTX HERON THERAPEUTICS INC More: the full row for HERON THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,140,271 shares; 2025Q1: 2,235,459 shares; 2025Q2: 2,135,459 shares; 2025Q3: 3,450,000 shares; 2025Q4: 6,250,000 shares; 2026Q1: 6,250,000 shares; 2026Q2: 6,250,000 shares; 2026Q3: 8,971,427 shares 8,971,427 $2.81M 0.13% +2,721,427 Timeline WVE WAVE LIFE SCIENCES INC More: the full row for WAVE LIFE SCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 600,000 shares 600,000 $2.22M 0.1% new Timeline ALT ALTIMMUNE INC More: the full row for ALTIMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,750,000 shares; 2025Q1: 2,750,000 shares; 2025Q2: 2,750,000 shares; 2025Q3: 2,131,307 shares; 2025Q4: 2,131,307 shares; 2026Q1: 666,022 shares; 2026Q2: 666,022 shares; 2026Q3: 666,022 shares 666,022 $1.9M 0.09% 0 Timeline LENZ LENZ THERAPEUTICS INC More: the full row for LENZ THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 766,940 shares; 2025Q1: 766,940 shares; 2025Q2: 897,616 shares; 2025Q3: 897,616 shares; 2025Q4: 865,169 shares; 2026Q1: 451,114 shares; 2026Q2: 451,114 shares; 2026Q3: 451,114 shares 451,114 $1.73M 0.08% 0 Timeline SION SIONNA THERAPEUTICS INC More: the full row for SIONNA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 125,000 shares 125,000 $658K 0.03% new Timeline SKYE SKYE BIOSCIENCE INC More: the full row for SKYE BIOSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000 $322K 0.01% new 2026-10-07, 13G : 263,560 shares, 6% of the class, 13G filed 2026-10-14 Timeline RCKT ROCKET PHARMACEUTICALS INC More: the full row for ROCKET PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 750,000 shares; 2025Q1: 850,000 shares; 2025Q2: 850,000 shares; 2025Q3: 850,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000 $263K 0.01% 0 Timeline